Spruce Biosciences, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$697K
$0
R&D↓-80.9% -$17M
$4M
D&A↓-44.4% -$4K
$5K
Operating Income↑+12.5% +$1M
$-8M
EBITDA↓-44.4% -$4K
$5K
Interest Expense↓-89.3% -$50K
$6K
Net Income↑+5.3% +$459K
$-8M
Operating Margin
-1562.8%
Net Margin
-1440.4%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
—
Operating Lease Cost
—
Revenue YoY Variation↓-24.1pts
-100.0%
Income YoY Variation↓-18.6pts
12.5%
Revenue QoQ Variation↓-69.3pts
-100.0%
Income QoQ Variation↓-211.9pts
-205.7%